Literature DB >> 16608956

Management of unsuccessful thrombolysis in acute massive pulmonary embolism.

Nicolas Meneveau1, Marie-France Séronde, Marie-Cécile Blonde, Pierre Legalery, Katy Didier-Petit, Florent Briand, Fiona Caulfield, François Schiele, Yvette Bernard, Jean-Pierre Bassand.   

Abstract

BACKGROUND: The management of patients with acute massive pulmonary embolism (PE) who do not respond to fibrinolytic therapy remains unclear. We aimed to compare rescue surgical embolectomy and repeat thrombolysis in patients who did not respond to thrombolysis.
METHODS: We conducted a prospective single-center registry of PE patients who underwent thrombolytic therapy. Lack of response to thrombolysis within the first 36 h was prospectively defined as both persistent clinical instability and residual echocardiographic right ventricular dysfunction. Patients underwent surgical embolectomy or repeat thrombolysis, at the discretion of the attending physician. The clinical end point was a combined end point including recurrent PE, bleeding complications, or PE-related death, which was defined as death from recurrent PE or cardiogenic shock. Long-term adverse outcomes included death, recurrent thromboembolic events, and congestive heart failure.
RESULTS: From January 1995 to January 2005, 488 PE patients underwent thrombolysis, of whom 40 (8.2%) did not respond to thrombolysis. Fourteen patients were treated by rescue surgical embolectomy, and 26 were treated by repeat thrombolysis. There was no significant difference in baseline characteristics between the two groups. The in-hospital course was uneventful in 11 of the surgically treated patients (79%) and in 8 patients (31%) treated by repeat thrombolysis (p = 0.004). There was a trend for higher mortality in the medical group than in the surgical group (10 vs 1 deaths, respectively; p = 0.07). There were significantly more recurrent PEs (fatal and nonfatal) in the repeat-thrombolysis group (35% vs 0%, respectively; p = 0.015). While no significant difference was observed in number of major bleeding events, all bleeding events in the repeat-thrombolysis group were fatal. The rate of uneventful long-term evolution was the same in the two groups.
CONCLUSION: Rescue surgical embolectomy led to a better in-hospital course when compared with repeat thrombolysis in patients with massive PE who have not responded to thrombolysis. The transfer of patients who have not responded to thrombolysis to tertiary cardiac surgery centers could be considered as an alternative option.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16608956     DOI: 10.1378/chest.129.4.1043

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  54 in total

1.  Aggressive approach to pulmonary embolectomy for massive acute pulmonary embolism: a historical and contemporary perspective.

Authors:  P Michael McFadden; John L Ochsner
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Surgical embolectomy for acute massive pulmonary embolism.

Authors:  Senol Yavuz; Faruk Toktas; Tugrul Goncu; Cuneyt Eris; Arif Gucu; Derih Ay; Burak Erdolu; Erhan Tenekecioglu; Kemal Karaagac; Hakan Vural; Ahmet Ozyazicioglu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 4.  Surgical embolectomy for acute massive pulmonary embolism: state of the art.

Authors:  Alessandra Iaccarino; Giacomo Frati; Leonardo Schirone; Wael Saade; Elio Iovine; Mizar D'Abramo; Antonio De Bellis; Sebastiano Sciarretta; Ernesto Greco
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

5.  Surgical pulmonary embolectomy: the resurrection of an almost discarded operation.

Authors:  Samuel Z Goldhaber
Journal:  Tex Heart Inst J       Date:  2013

Review 6.  Acute lung failure.

Authors:  Rob Mac Sweeney; Daniel F McAuley; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2011-10-11       Impact factor: 3.119

7.  A more aggressive approach to emergency embolectomy for acute pulmonary embolism.

Authors:  Basar Sareyyupoglu; Kevin L Greason; Rakesh M Suri; Mark T Keegan; Joseph A Dearani; Thoralf M Sundt
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

8.  Safety and efficacy of fondaparinux as an adjunctive treatment to thrombolysis in patients with high and intermediate risk pulmonary embolism.

Authors:  Sebastien Janin; Nicolas Meneveau; Ailiman Mahemuti; Vincent Descotes-Genon; Joanna Dutheil; Romain Chopard; Marie-France Seronde; Francois Schiele; Yvette Bernard; Jean-Pierre Bassand
Journal:  J Thromb Thrombolysis       Date:  2008-10-25       Impact factor: 2.300

9.  Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin.

Authors:  Carlos Jerjes-Sánchez; Sergio Villarreal-Umaña; Alicia Ramírez-Rivera; Anabel Garcia-Sosa; Luis Miguel-Canseco; Tamara Archondo; Esteban Reyes; Angel Garza; Roberto Arriaga; Francisco Castillo; Omar Jasso; Hector Garcia; Martha Bermudez; Jose Maria Hernandez; Jorge Garcia; Pedro Martinez; Francisco Rangel; Jorge Gutierrez; Alfredo Comparan-Nuñez
Journal:  J Thromb Thrombolysis       Date:  2008-01-19       Impact factor: 2.300

10.  Management of pulmonary embolism: state of the art treatment and emerging research.

Authors:  Omar Esponda; Alfonso Tafur
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.